Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175)
Cat.#: ASSD-175
Specifications
Description 5-Carboxyfluorescein-N-hydroxysuccinimide Ester, an amine-reactive fluorescent reagent, is used for labeling peptides, proteins, and nucleotides. The compound is a fluorescein derivative probe that yields carboxyamides that are more resistant to hydrolysis. Synonyms 5-FAM, SE Size 25 mg Applications Used for labeling peptides and nucleotides. Molecule Weight 473.39 Molecular formula C25H15NO9 CAS Number 92557-80-7 MDL Number MFCD00077322 Solubility Soluble in water (partly miscible), and DMSO. Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-118 BrdU (5-Bromo-2′-deoxyuridine) (AC118) 200 mg, 100 mg, 1 g, 5g inquiry ASSD-174 Coomassie Blue R-250 (AC174) 25 g, 100 g inquiry ASSD-159 Erythrosin B (AC159) 1g, 5g inquiry ASSD-165 FLUO 3-AM (AC165) 1 mg inquiry ASSD-156 Crystal Violet (AC156) 1g, 5g inquiry ASSD-222 Antifade Fluorescence Mounting Medium with Propidium Iodide (hard set) (AC222) 10 mL inquiry ASSD-218 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) 25 mg inquiry ASSD-117 Annexin V-PE Apoptosis Staining / Detection Kit (AC117) 1 kit, 100 tests inquiry ASSD-177 Fluorescein 5-Maleimide (AC177) 25 mg inquiry ASSD-120 Fluorescent adenosine antagonist [XAC] (AC120) 500 μg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket